DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

DRG and its group companies would like to inform you that we have updated our website privacy policy.

Acknowledge
› › 3

In the news

PM360

ELITE 2019 Mentor John Jaeger of Decision Resources Group

READ ARTICLE

In the news

Clinical Leader

A Cost-Utility Analysis Of Vertex's CF Drugs — What It Teaches Us About Trial Design

READ ARTICLE

In the news

Pharmaceutical Online

Lessons In Navigating The Increasingly Complex World Of Orphan Drug Commercialization

READ ARTICLE

In the news

Clinical Leader

Incorporating Patient-Centric Outcome Metrics In Rare Disease Trials

READ ARTICLE

In the news

Cell & gene

Spark's Luxturna Gene Therapy: What Can We Learn From Its Development & Commercialization?

READ ARTICLE

In the news

Cell & gene

The Gene Therapy Pipeline — And The Biggest Challenges Facing Developers

READ ARTICLE

In the news

MedCityNews

Clover Health is laying off a quarter of its workforce, two months after $500M fundraise

READ ARTICLE

In the news

PharmaLive

Agenda 2019 Special Feature: Hungry AIs

READ ARTICLE

In the news

PM360

Four Key Questions About Point of Care in 2019

READ ARTICLE

In the news

Specialty Pharmacy Continuum

ASHP Briefs Congress on Drug Pricing, Shortages

READ ARTICLE

In the news

Pharmacy Practice News

ASHP Briefs Congress on Drug Pricing, Shortages

READ ARTICLE

In the news

Outpatient Surgery

Your Endoscope Is On the Fritz, Now What?

READ ARTICLE
Load more